Commons2nd readingView on Parliament.uk

Medical Innovation (No. 2) Bill

A Bill to make provision about innovation in medical treatment.

Originating House

House of Commons

Last Updated

15 May 2014

In Plain English

AI-generated

The Medical Innovation (No. 2) Bill is a Commons measure aimed at making provision about innovation in medical treatment. At this early stage, the exact proposals are still to be debated and refined as the bill moves through Parliament.

Key Points

Purpose: to make provision about innovation in medical treatment.
Current stage: Second Reading in the House of Commons.
Origin and policy area: originated in the Commons and relates to healthcare.
Official documents: Explanatory Notes and the Bill accompany the measure.
Next steps: if it progresses, it would proceed to the Committee stage for detailed examination and then to further readings in both Houses.

Progress

The bill is currently at its Second Reading in the House of Commons. If it moves forward, it will go to the Committee stage for detailed scrutiny before continuing through the remaining parliamentary stages.

Who is affected?

Patients and potential recipients of new medical treatmentsNHS and other healthcare providersMedical researchers and cliniciansPharmaceutical, biotechnology and medical device companiesHealth tech startups and innovatorsRegulators and policymakers involved in medical treatment and patient safety

Generated 21 February 2026

Updates & Documents

News (1)

News - Medical Innovation (No. 2)

1 Jan 1970

This Bill was withdrawn and will not progress any further.

Documents (2)

Bill 107 EN 2013-14

Explanatory NotesCommons

12 Sept 2013

Bill 107 2013-14 (as introduced)

BillCommons

12 Sept 2013

Parliamentary Votes (0)

No recorded votes for this bill yet.

Medical Innovation (No. 2) Bill | TrackPolitics